Duearity AB (ST:DEAR) — Market Cap & Net Worth
Market Cap & Net Worth: Duearity AB (DEAR)
Duearity AB (ST:DEAR) has a market capitalization of $331.97K (Skr3.08 Million) as of May 4, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #30679 globally and #728 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Duearity AB's stock price Skr0.02 by its total outstanding shares 200308992 (200.31 Million). Analyse Duearity AB (DEAR) cash flow conversion to see how efficiently the company converts income to cash.
Duearity AB Market Cap History: 2021 to 2026
Duearity AB's market capitalization history from 2021 to 2026. Data shows change from $368.02 Million to $331.97K (-72.24% CAGR).
Duearity AB Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Duearity AB's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
28.93x
Duearity AB's market cap is 28.93 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $368.02 Million | $174.48K | -$15.52 Million | 2109.20x | N/A |
| 2022 | $145.40 Million | $598.00K | -$19.31 Million | 243.14x | N/A |
| 2023 | $47.86 Million | $1.65 Million | -$26.19 Million | 28.93x | N/A |
Competitor Companies of DEAR by Market Capitalization
Companies near Duearity AB in the global market cap rankings as of May 4, 2026.
Key companies related to Duearity AB by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #141 globally with a market cap of $155.56 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #208 globally with a market cap of $112.79 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #230 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #236 globally with a market cap of $102.56 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #141 | Abbott Laboratories | NYSE:ABT | $155.56 Billion | $89.46 |
| #208 | Stryker Corporation | NYSE:SYK | $112.79 Billion | $294.73 |
| #230 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #236 | Medtronic PLC | NYSE:MDT | $102.56 Billion | $80.00 |
Duearity AB Historical Marketcap From 2021 to 2026
Between 2021 and today, Duearity AB's market cap moved from $368.02 Million to $ 331.97K, with a yearly change of -72.24%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr331.97K | 0.00% |
| 2025 | Skr331.97K | 0.00% |
| 2024 | Skr331.97K | -99.31% |
| 2023 | Skr47.86 Million | -67.09% |
| 2022 | Skr145.40 Million | -60.49% |
| 2021 | Skr368.02 Million | -- |
End of Day Market Cap According to Different Sources
On May 3rd, 2026 the market cap of Duearity AB was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $331.97K USD |
| MoneyControl | $331.97K USD |
| MarketWatch | $331.97K USD |
| marketcap.company | $331.97K USD |
| Reuters | $331.97K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Duearity AB
Duearity AB (publ), a medical technology company, engages in the development and production of solutions for tinnitus. The company offers Tinearity G1, a medical device for people suffering from tinnitus that transmits white noise using bone conduction technology non-invasively to the inner ear in order to treat and relieve symptoms; and Tinearity-AI, which uses artificial intelligence to help pe… Read more